Search research articles
Contact Us
Filters
Showing results (911-920 of 1,002) with videos related to
Page
of 101
Sort By:
Journal of Medicinal Chemistry
|
July 9, 2014
Therapeutic potential of targeting the oncogenic SHP2 phosphatase
Li-Fan Zeng, Ruo-Yu Zhang, Zhi-Hong Yu, et al.
Nature
|
August 9, 2023
Reversed Holocene temperature-moisture relationship in the Horn of Africa
A J Baxter, D Verschuren, F Peterse, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 18, 2012
Serine/threonine acetylation of TGFβ-activated kinase (TAK1) by Yersinia pestis YopJ inhibits innate immune signaling
Nicholas Paquette, Joseph Conlon, Charles Sweet, et al.
Molecular and Cellular Biology
|
April 3, 2001
RBP1 recruits the mSIN3-histone deacetylase complex to the pocket of retinoblastoma tumor suppressor family proteins found in limited discrete regions of the nucleus at growth arrest
A Lai, B K Kennedy, D A Barbie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 23, 2010
Oral bisphosphonate use and breast cancer incidence in postmenopausal women
Rowan T Chlebowski, Zhao Chen, Jane A Cauley, et al.
The Journal of Infectious Diseases
|
January 1, 1997
Genetic heterogeneity of Borrelia burgdorferi in the United States
D A Mathiesen, J H Oliver, C P Kolbert, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|
February 14, 2018
Serum glucose and insulin and risk of cancers of the breast, endometrium, and ovary in postmenopausal women
Geoffrey C Kabat, Mimi Y Kim, Dorothy S Lane, et al.
International Journal of Cancer
|
March 7, 2014
Non-steroidal anti-inflammatory drugs and cancer risk in women: results from the Women's Health Initiative
Theodore M Brasky, Jingmin Liu, Emily White, et al.
JAMA
|
July 15, 2005
Symptom experience after discontinuing use of estrogen plus progestin
Judith K Ockene, David H Barad, Barbara B Cochrane, et al.
Journal of the National Cancer Institute
|
February 19, 2011
Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers
Ghada N Farhat, Steven R Cummings, Rowan T Chlebowski, et al.
Page
of 101
Search research articles
Search
Showing results (911-920 of 1,002) with videos related to
Sort By:
Page
of 101
Journal of Medicinal Chemistry
|
July 9, 2014
Therapeutic potential of targeting the oncogenic SHP2 phosphatase
Li-Fan Zeng, Ruo-Yu Zhang, Zhi-Hong Yu, et al.
Nature
|
August 9, 2023
Reversed Holocene temperature-moisture relationship in the Horn of Africa
A J Baxter, D Verschuren, F Peterse, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 18, 2012
Serine/threonine acetylation of TGFβ-activated kinase (TAK1) by Yersinia pestis YopJ inhibits innate immune signaling
Nicholas Paquette, Joseph Conlon, Charles Sweet, et al.
Molecular and Cellular Biology
|
April 3, 2001
RBP1 recruits the mSIN3-histone deacetylase complex to the pocket of retinoblastoma tumor suppressor family proteins found in limited discrete regions of the nucleus at growth arrest
A Lai, B K Kennedy, D A Barbie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 23, 2010
Oral bisphosphonate use and breast cancer incidence in postmenopausal women
Rowan T Chlebowski, Zhao Chen, Jane A Cauley, et al.
The Journal of Infectious Diseases
|
January 1, 1997
Genetic heterogeneity of Borrelia burgdorferi in the United States
D A Mathiesen, J H Oliver, C P Kolbert, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)
|
February 14, 2018
Serum glucose and insulin and risk of cancers of the breast, endometrium, and ovary in postmenopausal women
Geoffrey C Kabat, Mimi Y Kim, Dorothy S Lane, et al.
International Journal of Cancer
|
March 7, 2014
Non-steroidal anti-inflammatory drugs and cancer risk in women: results from the Women's Health Initiative
Theodore M Brasky, Jingmin Liu, Emily White, et al.
JAMA
|
July 15, 2005
Symptom experience after discontinuing use of estrogen plus progestin
Judith K Ockene, David H Barad, Barbara B Cochrane, et al.
Journal of the National Cancer Institute
|
February 19, 2011
Sex hormone levels and risks of estrogen receptor-negative and estrogen receptor-positive breast cancers
Ghada N Farhat, Steven R Cummings, Rowan T Chlebowski, et al.
Page
of 101